| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |